MTM essentials for anticoagulant management in cardiovascular disease

Atrial fibrillation and venous thromboembolism are prevalent, complex diseases that increase morbidity and mortality while reducing patients' quality of life. There has been a dramatic increase in anticoagulant choices available to prevent and treat thrombosis and prevent related complications....

Full description

Saved in:
Bibliographic Details
Published in:Drug Topics 2014-09, Vol.158 (9), p.42
Main Authors: White, C. Michael, Lee, Jiehyun
Format: Magazinearticle
Language:English
Subjects:
Anticoagulants
Anticoagulants (Medicine)
Aspirin
Atrial fibrillation
Cardiac arrhythmia
Cardiovascular disease
Cardiovascular diseases
Care and treatment
Chronic illnesses
Clinical trials
Compliance
Diabetes
Disease prevention
Drug interactions
Drug stores
Evidence-based medicine
Glycoproteins
Health aspects
Heart failure
Ischemia
Mortality
Patients
Pharmacists
Pharmacokinetics
Pharmacology
Stroke
Studies
Thromboembolism
Thrombolytic drugs
Thrombosis
Transient ischemic attack
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atrial fibrillation and venous thromboembolism are prevalent, complex diseases that increase morbidity and mortality while reducing patients' quality of life. There has been a dramatic increase in anticoagulant choices available to prevent and treat thrombosis and prevent related complications. Pharmacists play an important role in the prevention and management of thrombosis and can help to ensure the safe and effective use of evidence-based therapies to optimize outcomes. This article provides a review of the clinical features of each of the main drug classes used orally to treat thrombosis, including information on adverse events, monitoring, and drug-drug interactions.
ISSN:0012-6616
1937-8157